CN(C(=O)c1cccc(NC(=O)Cc2ccc(NC(=O)C3CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)cc2)c1)C1CCC1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?